Hikma Pharmaceuticals Plc Director/PDMR Shareholding

Data : 13/03/2019 @ 14:49
Fonte : UK Regulatory (RNS & others)
Titolo : Hikma Pharmaceuticals Plc (HIK)
Quotazione : 1889.0  12.0 (0.64%) @ 17:35
Quotazione Hikma Pharmaceuticals Grafico

Hikma Pharmaceuticals Plc Director/PDMR Shareholding

TIDMHIK

RNS Number : 7822S

Hikma Pharmaceuticals Plc

13 March 2019

Notification and public disclosure of transactions by persons discharging managerial responsibilities

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Said Darwazah 
 2    Reason for the notification 
 a)   Position/status           Executive Chairman 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Market purchase of 20,000 Ordinary Shares by 
       transaction               Capital Investment & Brokerage / Jordan Ltd. 
                                 Co for and on behalf of Said Darwazah. 
 c)   Price(s) and              Price(s): GBP15.9166 
       volume(s)                 Volume(s): 20,000 
 d)   Aggregated information 
        *    Volume               20,000 
                                 GBP318,332.00 
 
        *    Price 
 e)   Date of the transaction   13 March 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Peter Speirs

Company Secretary, responsible for releasing this announcement

+44 (0) 20 7399 2760

13 March 2019

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHBXGDXRSBBGCX

(END) Dow Jones Newswires

March 13, 2019 09:49 ET (13:49 GMT)

Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico

1 Anno : Da Nov 2018 a Nov 2019

Clicca qui per i Grafici di Hikma Pharmaceuticals

Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Intraday

Oggi : Domenica 17 Novembre 2019

Clicca qui per i Grafici di Hikma Pharmaceuticals
La tua Cronologia
BIT
BMPS
Monte Pasc..
BITI
FTSEMIB
FTSE Mib
BIT
UCG
Unicredit
NASDAQ
AAPL
Apple
FX
EURUSD
Euro vs Do..
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.

Registrati ora per creare la tua watchlist personalizzata in tempo reale streaming.

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

P: V:it D:20191117 21:38:23